Table 2 Comparison of immunostaining intensities and positive samples between groups of breast samples.
From: Influence of IFN-gamma and its receptors in human breast cancer
IFNγ | IFNγ-Rα | IFNγ-Rβ | |||||
|---|---|---|---|---|---|---|---|
% positive samples | Optical density | % positive samples | Optical density | % positive samples | Optical density | ||
cytoplasm | nucleus | ||||||
Benign lesions | 70,6% | 11.4 ± 2.5a | 88.2% | 14.9 ± 2.3a | 41.17% | 19.4 ± 2.8a | |
42.8% | 57.14% | ||||||
in situ carcinoma | 35% | 30.7 ± 8.1b | 41.4% | 18.2 ± 2.7a | 55.1% | 17.6 ± 4.1a | |
6.25% | 93.75% | ||||||
Infiltrating carcinoma | 40% | 18.9 ± 2.1a | 28.9% | 9.9 ± 2.1b | 22.2% | 18.6 ± 2.9a | |
20% | 80% | ||||||